Counselors in Prairie City, IA Accepting Medicare
2 Counselors found. Showing 1 - 2
 Mr. Marvin Fangman, M.A., IAADC Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 501 North Sherman, Prairie City, IA 50228 Phone: 515-994-3562 Fax: 515-994-3564 |
Charles G Ingle, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 E. Jefferson, Prairie City, IA 50228 Phone: 515-994-2617 Fax: 515-994-2365 |
News Archive
Actress Mandy Moore leads bipartisan congressional group to Cameroon to highlight disease prevention
"Actress, singer and humanitarian Mandy Moore recently led a bipartisan delegation of congressional staffers on a trip to Cameroon to promote foreign aid and disease prevention there," Foreign Policy's "The Cable" reports.
Japanese researchers explain how inflammation causes gastric tumors
In 1982, researchers reported a link between chronic gastritis and stomach bacterium Helicobacter pylori, triggering a flurry of research into this newly-identified pathogen.
Defective chemical bond in biological tissue may be the reason for diseases, say researchers
Researchers at Vanderbilt University Medical Center led by Billy Hudson, Ph.D., have discovered a new chemical bond in biological tissue, a fundamental discovery that helps explain evolutionary adaptation in the animal kingdom and may shed light on human disease.
World Health Summit provides platform to discuss incorporating NTDs into MDGs
In anticipation of next week's 2011 World Health Summit in Berlin, Germany, Neeraj Mistry, managing director of the Global Network for Neglected Tropical Disease, recaps gains in the treatment and prevention of neglected tropical diseases (NTDs) around the world through the commitment of the U.S., the U.K. and other G8 countries and makes the case for a global NTD initiative in the network's "End the Neglect" blog.
YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration
YM BioSciences Inc. today announced results of a collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The approach has successfully concluded its first series of proof-of-principle experiments establishing promise for future development and application.
› Verified 3 days ago